Funding for this research was provided by:
National Natural Science Foundation of China (31801085)
Natural Science Foundation of Shandong Province (ZR2018QH004)
Key Technology Research and Development Program of Shandong (2019GSF108174)
Received: 10 October 2019
Accepted: 13 November 2019
First Online: 9 December 2019
Change Date: 3 August 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: The experimental protocol was approved by the Research Ethics Committee of Binzhou Medical University, China (No. 2017-016-01 for human lung cancer specimen and No. 2017-009-09 for mouse experiments in vivo) and the written informed consent was obtained from all subjects. Informed consent was obtained from all individual participants included in the study. All patients were staged based on the criteria of the 7th Edition of the AJCC Cancer Staging Manual (2010).
: The authors confirm that they have obtained written consent from each patient to publish the manuscript.
: The authors have declared that no competing interest exists.